TR150_HUMAN - dbPTM
TR150_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TR150_HUMAN
UniProt AC Q9Y2W1
Protein Name Thyroid hormone receptor-associated protein 3
Gene Name THRAP3 {ECO:0000312|HGNC:HGNC:22964}
Organism Homo sapiens (Human).
Sequence Length 955
Subcellular Localization Nucleus . Nucleus, nucleoplasm . Nucleus speckle .
Protein Description Involved in pre-mRNA splicing. Remains associated with spliced mRNA after splicing which probably involves interactions with the exon junction complex (EJC). Can trigger mRNA decay which seems to be independent of nonsense-mediated decay involving premature stop codons (PTC) recognition. May be involved in nuclear mRNA decay. Involved in regulation of signal-induced alternative splicing. During splicing of PTPRC/CD45 is proposed to sequester phosphorylated SFPQ from PTPRC/CD45 pre-mRNA in resting T-cells. Involved in cyclin-D1/CCND1 mRNA stability probably by acting as component of the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. Involved in response to DNA damage. Is excluced from DNA damage sites in a manner that parallels transcription inhibition; the function may involve the SNARP complex. Initially thought to play a role in transcriptional coactivation through its association with the TRAP complex; however, it is not regarded as a stable Mediator complex subunit. Cooperatively with HELZ2, enhances the transcriptional activation mediated by PPARG, maybe through the stabilization of the PPARG binding to DNA in presence of ligand. May play a role in the terminal stage of adipocyte differentiation. Plays a role in the positive regulation of the circadian clock. Acts as a coactivator of the CLOCK-ARNTL/BMAL1 heterodimer and promotes its transcriptional activator activity and binding to circadian target genes. [PubMed: 24043798]
Protein Sequence MSKTNKSKSGSRSSRSRSASRSRSRSFSKSRSRSRSLSRSRKRRLSSRSRSRSYSPAHNRERNHPRVYQNRDFRGHNRGYRRPYYFRGRNRGFYPWGQYNRGGYGNYRSNWQNYRQAYSPRRGRSRSRSPKRRSPSPRSRSHSRNSDKSSSDRSRRSSSSRSSSNHSRVESSKRKSAKEKKSSSKDSRPSQAAGDNQGDEAKEQTFSGGTSQDTKASESSKPWPDATYGTGSASRASAVSELSPRERSPALKSPLQSVVVRRRSPRPSPVPKPSPPLSSTSQMGSTLPSGAGYQSGTHQGQFDHGSGSLSPSKKSPVGKSPPSTGSTYGSSQKEESAASGGAAYTKRYLEEQKTENGKDKEQKQTNTDKEKIKEKGSFSDTGLGDGKMKSDSFAPKTDSEKPFRGSQSPKRYKLRDDFEKKMADFHKEEMDDQDKDKAKGRKESEFDDEPKFMSKVIGANKNQEEEKSGKWEGLVYAPPGKEKQRKTEELEEESFPERSKKEDRGKRSEGGHRGFVPEKNFRVTAYKAVQEKSSSPPPRKTSESRDKLGAKGDFPTGKSSFSITREAQVNVRMDSFDEDLARPSGLLAQERKLCRDLVHSNKKEQEFRSIFQHIQSAQSQRSPSELFAQHIVTIVHHVKEHHFGSSGMTLHERFTKYLKRGTEQEAAKNKKSPEIHRRIDISPSTFRKHGLAHDEMKSPREPGYKAEGKYKDDPVDLRLDIERRKKHKERDLKRGKSRESVDSRDSSHSRERSAEKTEKTHKGSKKQKKHRRARDRSRSSSSSSQSSHSYKAEEYTEETEEREESTTGFDKSRLGTKDFVGPSERGGGRARGTFQFRARGRGWGRGNYSGNNNNNSNNDFQKRNREEEWDPEYTPKSKKYYLHDDREGEGSDKWVSRGRGRGAFPRGRGRFMFRKSSTSPKWAHDKFSGEEGEIEDDESGTENREEKDNIQPTTE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSKTNKSKS
------CCCCCCCCC
48.4622814378
2Phosphorylation------MSKTNKSKS
------CCCCCCCCC
48.4617287340
7Phosphorylation-MSKTNKSKSGSRSS
-CCCCCCCCCCCCCH
33.8421601212
16PhosphorylationSGSRSSRSRSASRSR
CCCCCHHCHHHHHHH
32.3221601212
17MethylationGSRSSRSRSASRSRS
CCCCHHCHHHHHHHH
34.82-
20PhosphorylationSSRSRSASRSRSRSF
CHHCHHHHHHHHHHH
31.8422210691
22PhosphorylationRSRSASRSRSRSFSK
HCHHHHHHHHHHHHH
31.9221601212
24PhosphorylationRSASRSRSRSFSKSR
HHHHHHHHHHHHHHH
33.2623663014
26PhosphorylationASRSRSRSFSKSRSR
HHHHHHHHHHHHHHH
34.8123663014
28PhosphorylationRSRSRSFSKSRSRSR
HHHHHHHHHHHHHHH
30.8523663014
30PhosphorylationRSRSFSKSRSRSRSL
HHHHHHHHHHHHHHH
34.0023663014
32PhosphorylationRSFSKSRSRSRSLSR
HHHHHHHHHHHHHCH
41.5224300666
34PhosphorylationFSKSRSRSRSLSRSR
HHHHHHHHHHHCHHH
27.7122817900
36PhosphorylationKSRSRSRSLSRSRKR
HHHHHHHHHCHHHHH
31.7622817900
38PhosphorylationRSRSRSLSRSRKRRL
HHHHHHHCHHHHHHH
29.4724300666
40PhosphorylationRSRSLSRSRKRRLSS
HHHHHCHHHHHHHHH
38.4824144214
46PhosphorylationRSRKRRLSSRSRSRS
HHHHHHHHHHHHCCC
23.1529116813
47PhosphorylationSRKRRLSSRSRSRSY
HHHHHHHHHHHCCCC
38.5829116813
49PhosphorylationKRRLSSRSRSRSYSP
HHHHHHHHHCCCCCC
36.2323663014
51PhosphorylationRLSSRSRSRSYSPAH
HHHHHHHCCCCCCCC
27.1622167270
53PhosphorylationSSRSRSRSYSPAHNR
HHHHHCCCCCCCCCC
31.0722167270
54PhosphorylationSRSRSRSYSPAHNRE
HHHHCCCCCCCCCCC
19.9830266825
55PhosphorylationRSRSRSYSPAHNRER
HHHCCCCCCCCCCCC
19.5022167270
62MethylationSPAHNRERNHPRVYQ
CCCCCCCCCCCCCCC
43.45115918901
64UbiquitinationAHNRERNHPRVYQNR
CCCCCCCCCCCCCCC
20.1221890473
66Asymmetric dimethylarginineNRERNHPRVYQNRDF
CCCCCCCCCCCCCCC
32.02-
66MethylationNRERNHPRVYQNRDF
CCCCCCCCCCCCCCC
32.0224129315
68PhosphorylationERNHPRVYQNRDFRG
CCCCCCCCCCCCCCC
11.0122817900
68UbiquitinationERNHPRVYQNRDFRG
CCCCCCCCCCCCCCC
11.0122817900
71DimethylationHPRVYQNRDFRGHNR
CCCCCCCCCCCCCCC
28.99-
71MethylationHPRVYQNRDFRGHNR
CCCCCCCCCCCCCCC
28.9954560303
74DimethylationVYQNRDFRGHNRGYR
CCCCCCCCCCCCCCC
50.15-
74MethylationVYQNRDFRGHNRGYR
CCCCCCCCCCCCCCC
50.1554560311
78MethylationRDFRGHNRGYRRPYY
CCCCCCCCCCCCCCE
37.53115918905
80UbiquitinationFRGHNRGYRRPYYFR
CCCCCCCCCCCCEEC
10.5422817900
81MethylationRGHNRGYRRPYYFRG
CCCCCCCCCCCEECC
35.60115918913
83UbiquitinationHNRGYRRPYYFRGRN
CCCCCCCCCEECCCC
21.1221890473
87MethylationYRRPYYFRGRNRGFY
CCCCCEECCCCCCCC
27.3424395845
91DimethylationYYFRGRNRGFYPWGQ
CEECCCCCCCCCCCC
34.93-
91MethylationYYFRGRNRGFYPWGQ
CEECCCCCCCCCCCC
34.9354560287
94PhosphorylationRGRNRGFYPWGQYNR
CCCCCCCCCCCCCCC
10.8228152594
101Asymmetric dimethylarginineYPWGQYNRGGYGNYR
CCCCCCCCCCCCCCC
34.67-
101MethylationYPWGQYNRGGYGNYR
CCCCCCCCCCCCCCC
34.6724129315
107PhosphorylationNRGGYGNYRSNWQNY
CCCCCCCCCCCHHHH
15.8522817900
108Asymmetric dimethylarginineRGGYGNYRSNWQNYR
CCCCCCCCCCHHHHH
27.75-
108MethylationRGGYGNYRSNWQNYR
CCCCCCCCCCHHHHH
27.7524129315
114PhosphorylationYRSNWQNYRQAYSPR
CCCCHHHHHHHCCCC
6.76-
115MethylationRSNWQNYRQAYSPRR
CCCHHHHHHHCCCCC
23.3983364511
118PhosphorylationWQNYRQAYSPRRGRS
HHHHHHHCCCCCCCC
15.7426846344
119PhosphorylationQNYRQAYSPRRGRSR
HHHHHHCCCCCCCCC
18.2328355574
132UbiquitinationSRSRSPKRRSPSPRS
CCCCCCCCCCCCCCC
47.9321890473
134PhosphorylationSRSPKRRSPSPRSRS
CCCCCCCCCCCCCCC
33.4927273156
136PhosphorylationSPKRRSPSPRSRSHS
CCCCCCCCCCCCCCC
33.9027273156
139PhosphorylationRRSPSPRSRSHSRNS
CCCCCCCCCCCCCCC
41.3323403867
143PhosphorylationSPRSRSHSRNSDKSS
CCCCCCCCCCCCCCC
34.11-
149PhosphorylationHSRNSDKSSSDRSRR
CCCCCCCCCCHHHHH
39.81-
150PhosphorylationSRNSDKSSSDRSRRS
CCCCCCCCCHHHHHH
41.83-
151PhosphorylationRNSDKSSSDRSRRSS
CCCCCCCCHHHHHHH
44.10-
154PhosphorylationDKSSSDRSRRSSSSR
CCCCCHHHHHHHCCC
36.72-
157PhosphorylationSSDRSRRSSSSRSSS
CCHHHHHHHCCCCHH
33.2023322592
158PhosphorylationSDRSRRSSSSRSSSN
CHHHHHHHCCCCHHH
30.4425884760
159PhosphorylationDRSRRSSSSRSSSNH
HHHHHHHCCCCHHHH
30.9025599653
160PhosphorylationRSRRSSSSRSSSNHS
HHHHHHCCCCHHHHH
37.8225599653
162PhosphorylationRRSSSSRSSSNHSRV
HHHHCCCCHHHHHHH
39.8125599653
163PhosphorylationRSSSSRSSSNHSRVE
HHHCCCCHHHHHHHH
33.7725884760
164PhosphorylationSSSSRSSSNHSRVES
HHCCCCHHHHHHHHH
39.5525849741
167PhosphorylationSRSSSNHSRVESSKR
CCCHHHHHHHHHHHH
42.1225849741
171PhosphorylationSNHSRVESSKRKSAK
HHHHHHHHHHHHHHH
38.0026846344
171UbiquitinationSNHSRVESSKRKSAK
HHHHHHHHHHHHHHH
38.0021890473
172PhosphorylationNHSRVESSKRKSAKE
HHHHHHHHHHHHHHH
23.9923322592
178AcetylationSSKRKSAKEKKSSSK
HHHHHHHHHHHCCCC
76.7218530807
178UbiquitinationSSKRKSAKEKKSSSK
HHHHHHHHHHHCCCC
76.7224816145
182PhosphorylationKSAKEKKSSSKDSRP
HHHHHHHCCCCCCCH
51.4128176443
183PhosphorylationSAKEKKSSSKDSRPS
HHHHHHCCCCCCCHH
50.7328176443
184PhosphorylationAKEKKSSSKDSRPSQ
HHHHHCCCCCCCHHH
47.8025159151
185AcetylationKEKKSSSKDSRPSQA
HHHHCCCCCCCHHHH
62.7726051181
187PhosphorylationKKSSSKDSRPSQAAG
HHCCCCCCCHHHHCC
50.2325159151
190PhosphorylationSSKDSRPSQAAGDNQ
CCCCCCHHHHCCCCC
31.2025159151
202"N6,N6-dimethyllysine"DNQGDEAKEQTFSGG
CCCCHHHHHHCCCCC
48.59-
202AcetylationDNQGDEAKEQTFSGG
CCCCHHHHHHCCCCC
48.5926051181
202MethylationDNQGDEAKEQTFSGG
CCCCHHHHHHCCCCC
48.59-
202SumoylationDNQGDEAKEQTFSGG
CCCCHHHHHHCCCCC
48.5925114211
202UbiquitinationDNQGDEAKEQTFSGG
CCCCHHHHHHCCCCC
48.5929967540
205PhosphorylationGDEAKEQTFSGGTSQ
CHHHHHHCCCCCCCC
22.3629255136
207PhosphorylationEAKEQTFSGGTSQDT
HHHHHCCCCCCCCCC
39.4329255136
210PhosphorylationEQTFSGGTSQDTKAS
HHCCCCCCCCCCCCC
27.0923401153
211PhosphorylationQTFSGGTSQDTKASE
HCCCCCCCCCCCCCC
29.3617525332
214PhosphorylationSGGTSQDTKASESSK
CCCCCCCCCCCCCCC
22.3728176443
215SumoylationGGTSQDTKASESSKP
CCCCCCCCCCCCCCC
59.2028112733
215UbiquitinationGGTSQDTKASESSKP
CCCCCCCCCCCCCCC
59.2023000965
217PhosphorylationTSQDTKASESSKPWP
CCCCCCCCCCCCCCC
39.3023403867
219PhosphorylationQDTKASESSKPWPDA
CCCCCCCCCCCCCCC
40.9625159151
220PhosphorylationDTKASESSKPWPDAT
CCCCCCCCCCCCCCC
38.3923927012
221AcetylationTKASESSKPWPDATY
CCCCCCCCCCCCCCC
61.4519608861
221SumoylationTKASESSKPWPDATY
CCCCCCCCCCCCCCC
61.4528112733
221UbiquitinationTKASESSKPWPDATY
CCCCCCCCCCCCCCC
61.4523000965
227PhosphorylationSKPWPDATYGTGSAS
CCCCCCCCCCCCCHH
29.8423927012
228PhosphorylationKPWPDATYGTGSASR
CCCCCCCCCCCCHHH
17.8927273156
230PhosphorylationWPDATYGTGSASRAS
CCCCCCCCCCHHHHH
19.9722167270
232PhosphorylationDATYGTGSASRASAV
CCCCCCCCHHHHHHH
23.9422167270
234PhosphorylationTYGTGSASRASAVSE
CCCCCCHHHHHHHHH
30.0323401153
237PhosphorylationTGSASRASAVSELSP
CCCHHHHHHHHHCCH
28.2629255136
240PhosphorylationASRASAVSELSPRER
HHHHHHHHHCCHHHC
32.3229255136
243PhosphorylationASAVSELSPRERSPA
HHHHHHCCHHHCCHH
20.1919664994
248PhosphorylationELSPRERSPALKSPL
HCCHHHCCHHHCCCC
15.1219664994
252AcetylationRERSPALKSPLQSVV
HHCCHHHCCCCEEEE
52.7325953088
252MethylationRERSPALKSPLQSVV
HHCCHHHCCCCEEEE
52.7324129315
252SumoylationRERSPALKSPLQSVV
HHCCHHHCCCCEEEE
52.7328112733
252UbiquitinationRERSPALKSPLQSVV
HHCCHHHCCCCEEEE
52.7333845483
253PhosphorylationERSPALKSPLQSVVV
HCCHHHCCCCEEEEE
31.5219664994
257PhosphorylationALKSPLQSVVVRRRS
HHCCCCEEEEEECCC
25.2726846344
264PhosphorylationSVVVRRRSPRPSPVP
EEEEECCCCCCCCCC
24.3723401153
268PhosphorylationRRRSPRPSPVPKPSP
ECCCCCCCCCCCCCC
39.5523401153
274PhosphorylationPSPVPKPSPPLSSTS
CCCCCCCCCCCCCCC
45.3223663014
278PhosphorylationPKPSPPLSSTSQMGS
CCCCCCCCCCCCCCC
37.0323663014
279PhosphorylationKPSPPLSSTSQMGST
CCCCCCCCCCCCCCC
39.5023663014
280PhosphorylationPSPPLSSTSQMGSTL
CCCCCCCCCCCCCCC
21.4323663014
281PhosphorylationSPPLSSTSQMGSTLP
CCCCCCCCCCCCCCC
21.8123663014
285PhosphorylationSSTSQMGSTLPSGAG
CCCCCCCCCCCCCCC
22.7922167270
286PhosphorylationSTSQMGSTLPSGAGY
CCCCCCCCCCCCCCC
36.6423663014
289PhosphorylationQMGSTLPSGAGYQSG
CCCCCCCCCCCCCCC
44.3723401153
293PhosphorylationTLPSGAGYQSGTHQG
CCCCCCCCCCCCCCC
10.0422167270
295PhosphorylationPSGAGYQSGTHQGQF
CCCCCCCCCCCCCCC
36.8623401153
297PhosphorylationGAGYQSGTHQGQFDH
CCCCCCCCCCCCCCC
19.1022167270
306PhosphorylationQGQFDHGSGSLSPSK
CCCCCCCCCCCCCCC
23.0723401153
308PhosphorylationQFDHGSGSLSPSKKS
CCCCCCCCCCCCCCC
27.6323401153
310PhosphorylationDHGSGSLSPSKKSPV
CCCCCCCCCCCCCCC
28.9123401153
312PhosphorylationGSGSLSPSKKSPVGK
CCCCCCCCCCCCCCC
49.7122167270
315PhosphorylationSLSPSKKSPVGKSPP
CCCCCCCCCCCCCCC
28.6723927012
320PhosphorylationKKSPVGKSPPSTGST
CCCCCCCCCCCCCCC
35.7929255136
323PhosphorylationPVGKSPPSTGSTYGS
CCCCCCCCCCCCCCC
49.1129255136
324PhosphorylationVGKSPPSTGSTYGSS
CCCCCCCCCCCCCCC
40.7129255136
324UbiquitinationVGKSPPSTGSTYGSS
CCCCCCCCCCCCCCC
40.7124816145
326PhosphorylationKSPPSTGSTYGSSQK
CCCCCCCCCCCCCHH
20.6720201521
327PhosphorylationSPPSTGSTYGSSQKE
CCCCCCCCCCCCHHH
32.9920201521
328PhosphorylationPPSTGSTYGSSQKEE
CCCCCCCCCCCHHHH
19.3920201521
330PhosphorylationSTGSTYGSSQKEESA
CCCCCCCCCHHHHHH
21.1230278072
331PhosphorylationTGSTYGSSQKEESAA
CCCCCCCCHHHHHHH
40.6930278072
333AcetylationSTYGSSQKEESAASG
CCCCCCHHHHHHHCC
66.4526051181
333SumoylationSTYGSSQKEESAASG
CCCCCCHHHHHHHCC
66.4528112733
336PhosphorylationGSSQKEESAASGGAA
CCCHHHHHHHCCCHH
30.1729255136
339PhosphorylationQKEESAASGGAAYTK
HHHHHHHCCCHHHHH
37.1629255136
344PhosphorylationAASGGAAYTKRYLEE
HHCCCHHHHHHHHHH
16.5623927012
345PhosphorylationASGGAAYTKRYLEEQ
HCCCHHHHHHHHHHH
12.3423403867
3462-HydroxyisobutyrylationSGGAAYTKRYLEEQK
CCCHHHHHHHHHHHC
26.77-
346AcetylationSGGAAYTKRYLEEQK
CCCHHHHHHHHHHHC
26.7725953088
346NeddylationSGGAAYTKRYLEEQK
CCCHHHHHHHHHHHC
26.7732015554
346SumoylationSGGAAYTKRYLEEQK
CCCHHHHHHHHHHHC
26.7728112733
346UbiquitinationSGGAAYTKRYLEEQK
CCCHHHHHHHHHHHC
26.7732015554
348PhosphorylationGAAYTKRYLEEQKTE
CHHHHHHHHHHHCCC
21.7418452278
353SumoylationKRYLEEQKTENGKDK
HHHHHHHCCCCCCCH
62.1728112733
354PhosphorylationRYLEEQKTENGKDKE
HHHHHHCCCCCCCHH
34.0828555341
365PhosphorylationKDKEQKQTNTDKEKI
CCHHHHCCCCCHHHH
47.31-
367PhosphorylationKEQKQTNTDKEKIKE
HHHHCCCCCHHHHHH
52.41-
3712-HydroxyisobutyrylationQTNTDKEKIKEKGSF
CCCCCHHHHHHHCCC
65.89-
373AcetylationNTDKEKIKEKGSFSD
CCCHHHHHHHCCCCC
65.5225953088
3752-HydroxyisobutyrylationDKEKIKEKGSFSDTG
CHHHHHHHCCCCCCC
55.65-
375AcetylationDKEKIKEKGSFSDTG
CHHHHHHHCCCCCCC
55.6525953088
375SumoylationDKEKIKEKGSFSDTG
CHHHHHHHCCCCCCC
55.6528112733
375UbiquitinationDKEKIKEKGSFSDTG
CHHHHHHHCCCCCCC
55.6532015554
377PhosphorylationEKIKEKGSFSDTGLG
HHHHHHCCCCCCCCC
32.4229255136
379PhosphorylationIKEKGSFSDTGLGDG
HHHHCCCCCCCCCCC
35.6419664994
381PhosphorylationEKGSFSDTGLGDGKM
HHCCCCCCCCCCCCC
32.8622167270
387SumoylationDTGLGDGKMKSDSFA
CCCCCCCCCCCCCCC
48.14-
387AcetylationDTGLGDGKMKSDSFA
CCCCCCCCCCCCCCC
48.1423954790
387SumoylationDTGLGDGKMKSDSFA
CCCCCCCCCCCCCCC
48.1425114211
387UbiquitinationDTGLGDGKMKSDSFA
CCCCCCCCCCCCCCC
48.1433845483
389SumoylationGLGDGKMKSDSFAPK
CCCCCCCCCCCCCCC
55.3828112733
389UbiquitinationGLGDGKMKSDSFAPK
CCCCCCCCCCCCCCC
55.3832015554
390O-linked_GlycosylationLGDGKMKSDSFAPKT
CCCCCCCCCCCCCCC
34.6830379171
390PhosphorylationLGDGKMKSDSFAPKT
CCCCCCCCCCCCCCC
34.6830108239
392PhosphorylationDGKMKSDSFAPKTDS
CCCCCCCCCCCCCCC
30.3330108239
396SumoylationKSDSFAPKTDSEKPF
CCCCCCCCCCCCCCC
62.6328112733
397PhosphorylationSDSFAPKTDSEKPFR
CCCCCCCCCCCCCCC
43.6425159151
399PhosphorylationSFAPKTDSEKPFRGS
CCCCCCCCCCCCCCC
53.3923927012
401AcetylationAPKTDSEKPFRGSQS
CCCCCCCCCCCCCCC
54.1023749302
401SumoylationAPKTDSEKPFRGSQS
CCCCCCCCCCCCCCC
54.1028112733
406PhosphorylationSEKPFRGSQSPKRYK
CCCCCCCCCCCCCCC
24.1923927012
408PhosphorylationKPFRGSQSPKRYKLR
CCCCCCCCCCCCCCH
33.8023927012
412PhosphorylationGSQSPKRYKLRDDFE
CCCCCCCCCCHHHHH
22.0926074081
4202-HydroxyisobutyrylationKLRDDFEKKMADFHK
CCHHHHHHHHHHHHH
48.09-
420AcetylationKLRDDFEKKMADFHK
CCHHHHHHHHHHHHH
48.0923749302
421SumoylationLRDDFEKKMADFHKE
CHHHHHHHHHHHHHH
31.9328112733
427SumoylationKKMADFHKEEMDDQD
HHHHHHHHHHCCHHH
56.19-
427AcetylationKKMADFHKEEMDDQD
HHHHHHHHHHCCHHH
56.1926051181
427SumoylationKKMADFHKEEMDDQD
HHHHHHHHHHCCHHH
56.1928112733
435AcetylationEEMDDQDKDKAKGRK
HHCCHHHHHHHCCCC
56.3426051181
442TrimethylationKDKAKGRKESEFDDE
HHHHCCCCHHHCCCC
74.41-
442MethylationKDKAKGRKESEFDDE
HHHHCCCCHHHCCCC
74.41-
444PhosphorylationKAKGRKESEFDDEPK
HHCCCCHHHCCCCHH
46.7423401153
451SumoylationSEFDDEPKFMSKVIG
HHCCCCHHHHHHHHC
52.21-
4512-HydroxyisobutyrylationSEFDDEPKFMSKVIG
HHCCCCHHHHHHHHC
52.21-
451SumoylationSEFDDEPKFMSKVIG
HHCCCCHHHHHHHHC
52.2125114211
451UbiquitinationSEFDDEPKFMSKVIG
HHCCCCHHHHHHHHC
52.2121906983
455AcetylationDEPKFMSKVIGANKN
CCHHHHHHHHCCCCC
26.5319608861
455SumoylationDEPKFMSKVIGANKN
CCHHHHHHHHCCCCC
26.5328112733
455UbiquitinationDEPKFMSKVIGANKN
CCHHHHHHHHCCCCC
26.5322817900
461SumoylationSKVIGANKNQEEEKS
HHHHCCCCCHHHHHC
60.52-
4612-HydroxyisobutyrylationSKVIGANKNQEEEKS
HHHHCCCCCHHHHHC
60.52-
461AcetylationSKVIGANKNQEEEKS
HHHHCCCCCHHHHHC
60.5226051181
461SumoylationSKVIGANKNQEEEKS
HHHHCCCCCHHHHHC
60.5228112733
461UbiquitinationSKVIGANKNQEEEKS
HHHHCCCCCHHHHHC
60.52-
467SumoylationNKNQEEEKSGKWEGL
CCCHHHHHCCCEECE
68.72-
467SumoylationNKNQEEEKSGKWEGL
CCCHHHHHCCCEECE
68.7228112733
467UbiquitinationNKNQEEEKSGKWEGL
CCCHHHHHCCCEECE
68.7222817900
468PhosphorylationKNQEEEKSGKWEGLV
CCHHHHHCCCEECEE
49.2121945579
470SumoylationQEEEKSGKWEGLVYA
HHHHHCCCEECEEEC
49.52-
470AcetylationQEEEKSGKWEGLVYA
HHHHHCCCEECEEEC
49.5223954790
470SumoylationQEEEKSGKWEGLVYA
HHHHHCCCEECEEEC
49.5228112733
470UbiquitinationQEEEKSGKWEGLVYA
HHHHHCCCEECEEEC
49.5221906983
476PhosphorylationGKWEGLVYAPPGKEK
CCEECEEECCCCCHH
20.5921945579
4812-HydroxyisobutyrylationLVYAPPGKEKQRKTE
EEECCCCCHHHHCHH
68.46-
481AcetylationLVYAPPGKEKQRKTE
EEECCCCCHHHHCHH
68.4625953088
481MalonylationLVYAPPGKEKQRKTE
EEECCCCCHHHHCHH
68.4630639696
481SumoylationLVYAPPGKEKQRKTE
EEECCCCCHHHHCHH
68.4628112733
483AcetylationYAPPGKEKQRKTEEL
ECCCCCHHHHCHHHH
59.917363963
486SumoylationPGKEKQRKTEELEEE
CCCHHHHCHHHHHHH
58.77-
486AcetylationPGKEKQRKTEELEEE
CCCHHHHCHHHHHHH
58.7726051181
486SumoylationPGKEKQRKTEELEEE
CCCHHHHCHHHHHHH
58.7728112733
486UbiquitinationPGKEKQRKTEELEEE
CCCHHHHCHHHHHHH
58.7733845483
487PhosphorylationGKEKQRKTEELEEES
CCHHHHCHHHHHHHH
36.5623401153
494PhosphorylationTEELEEESFPERSKK
HHHHHHHHCCHHHCC
49.7525159151
499PhosphorylationEESFPERSKKEDRGK
HHHCCHHHCCHHCCC
46.5525159151
500MethylationESFPERSKKEDRGKR
HHCCHHHCCHHCCCC
67.42116254045
508PhosphorylationKEDRGKRSEGGHRGF
CHHCCCCCCCCCCCC
44.0425159151
513MethylationKRSEGGHRGFVPEKN
CCCCCCCCCCCCCCC
43.4512020415
5192-HydroxyisobutyrylationHRGFVPEKNFRVTAY
CCCCCCCCCEEEEEH
56.14-
519AcetylationHRGFVPEKNFRVTAY
CCCCCCCCCEEEEEH
56.1419608861
519MalonylationHRGFVPEKNFRVTAY
CCCCCCCCCEEEEEH
56.1426320211
519UbiquitinationHRGFVPEKNFRVTAY
CCCCCCCCCEEEEEH
56.1427667366
524PhosphorylationPEKNFRVTAYKAVQE
CCCCEEEEEHHHHHH
21.7326074081
526PhosphorylationKNFRVTAYKAVQEKS
CCEEEEEHHHHHHHC
7.0726074081
527AcetylationNFRVTAYKAVQEKSS
CEEEEEHHHHHHHCC
39.3523749302
527SumoylationNFRVTAYKAVQEKSS
CEEEEEHHHHHHHCC
39.3528112733
533PhosphorylationYKAVQEKSSSPPPRK
HHHHHHHCCCCCCCC
34.9830266825
534PhosphorylationKAVQEKSSSPPPRKT
HHHHHHCCCCCCCCC
58.9130266825
535PhosphorylationAVQEKSSSPPPRKTS
HHHHHCCCCCCCCCC
48.8230266825
541PhosphorylationSSPPPRKTSESRDKL
CCCCCCCCCHHHHHH
38.7226074081
542PhosphorylationSPPPRKTSESRDKLG
CCCCCCCCHHHHHHC
36.2926074081
544PhosphorylationPPRKTSESRDKLGAK
CCCCCCHHHHHHCCC
45.6126074081
551AcetylationSRDKLGAKGDFPTGK
HHHHHCCCCCCCCCC
58.1626051181
551NeddylationSRDKLGAKGDFPTGK
HHHHHCCCCCCCCCC
58.1632015554
551SumoylationSRDKLGAKGDFPTGK
HHHHHCCCCCCCCCC
58.1628112733
551UbiquitinationSRDKLGAKGDFPTGK
HHHHHCCCCCCCCCC
58.1632015554
556PhosphorylationGAKGDFPTGKSSFSI
CCCCCCCCCCCCEEE
58.1826074081
558AcetylationKGDFPTGKSSFSITR
CCCCCCCCCCEEEEE
45.4625953088
558NeddylationKGDFPTGKSSFSITR
CCCCCCCCCCEEEEE
45.4632015554
558SumoylationKGDFPTGKSSFSITR
CCCCCCCCCCEEEEE
45.4628112733
558UbiquitinationKGDFPTGKSSFSITR
CCCCCCCCCCEEEEE
45.4621906983
559PhosphorylationGDFPTGKSSFSITRE
CCCCCCCCCEEEEEE
37.6530266825
560PhosphorylationDFPTGKSSFSITREA
CCCCCCCCEEEEEEE
26.8830266825
562PhosphorylationPTGKSSFSITREAQV
CCCCCCEEEEEEEEE
25.6223401153
564PhosphorylationGKSSFSITREAQVNV
CCCCEEEEEEEEEEE
22.6619691289
573SulfoxidationEAQVNVRMDSFDEDL
EEEEEEECCCCCHHH
4.3921406390
575PhosphorylationQVNVRMDSFDEDLAR
EEEEECCCCCHHHHC
25.8429255136
584PhosphorylationDEDLARPSGLLAQER
CHHHHCCCCHHHHHH
36.2023927012
600PhosphorylationLCRDLVHSNKKEQEF
HHHHHHHCCHHHHHH
42.7525159151
6022-HydroxyisobutyrylationRDLVHSNKKEQEFRS
HHHHHCCHHHHHHHH
61.78-
602SumoylationRDLVHSNKKEQEFRS
HHHHHCCHHHHHHHH
61.7828112733
602UbiquitinationRDLVHSNKKEQEFRS
HHHHHCCHHHHHHHH
61.7824816145
609PhosphorylationKKEQEFRSIFQHIQS
HHHHHHHHHHHHHHH
32.8324732914
616PhosphorylationSIFQHIQSAQSQRSP
HHHHHHHHHHHCCCH
27.8924732914
619PhosphorylationQHIQSAQSQRSPSEL
HHHHHHHHCCCHHHH
27.5525849741
622PhosphorylationQSAQSQRSPSELFAQ
HHHHHCCCHHHHHHH
25.7430266825
624PhosphorylationAQSQRSPSELFAQHI
HHHCCCHHHHHHHHH
48.4530266825
633PhosphorylationLFAQHIVTIVHHVKE
HHHHHHHHHHHHHHH
19.3724732914
639AcetylationVTIVHHVKEHHFGSS
HHHHHHHHHHCCCCC
47.1511921623
645PhosphorylationVKEHHFGSSGMTLHE
HHHHCCCCCCCCHHH
23.8322210691
646PhosphorylationKEHHFGSSGMTLHER
HHHCCCCCCCCHHHH
32.7222210691
657PhosphorylationLHERFTKYLKRGTEQ
HHHHHHHHHHHCHHH
17.8827251275
662PhosphorylationTKYLKRGTEQEAAKN
HHHHHHCHHHHHHHH
38.2320068231
672PhosphorylationEAAKNKKSPEIHRRI
HHHHHCCCHHHHHCC
29.4022167270
682PhosphorylationIHRRIDISPSTFRKH
HHHCCCCCHHHHHHH
14.7319664994
684PhosphorylationRRIDISPSTFRKHGL
HCCCCCHHHHHHHCC
33.1322167270
685PhosphorylationRIDISPSTFRKHGLA
CCCCCHHHHHHHCCC
30.7322167270
6972-HydroxyisobutyrylationGLAHDEMKSPREPGY
CCCCCCCCCCCCCCC
56.09-
697AcetylationGLAHDEMKSPREPGY
CCCCCCCCCCCCCCC
56.0926822725
697SumoylationGLAHDEMKSPREPGY
CCCCCCCCCCCCCCC
56.0928112733
697UbiquitinationGLAHDEMKSPREPGY
CCCCCCCCCCCCCCC
56.0932015554
698PhosphorylationLAHDEMKSPREPGYK
CCCCCCCCCCCCCCC
28.0729255136
704PhosphorylationKSPREPGYKAEGKYK
CCCCCCCCCCCCCCC
20.1023927012
705SumoylationSPREPGYKAEGKYKD
CCCCCCCCCCCCCCC
45.97-
705AcetylationSPREPGYKAEGKYKD
CCCCCCCCCCCCCCC
45.9725953088
705SumoylationSPREPGYKAEGKYKD
CCCCCCCCCCCCCCC
45.9728112733
709AcetylationPGYKAEGKYKDDPVD
CCCCCCCCCCCCCCH
40.4019608861
709SumoylationPGYKAEGKYKDDPVD
CCCCCCCCCCCCCCH
40.4028112733
710NitrationGYKAEGKYKDDPVDL
CCCCCCCCCCCCCHH
30.42-
710PhosphorylationGYKAEGKYKDDPVDL
CCCCCCCCCCCCCHH
30.42-
711SumoylationYKAEGKYKDDPVDLR
CCCCCCCCCCCCHHH
60.17-
7112-HydroxyisobutyrylationYKAEGKYKDDPVDLR
CCCCCCCCCCCCHHH
60.17-
711AcetylationYKAEGKYKDDPVDLR
CCCCCCCCCCCCHHH
60.1725953088
711MethylationYKAEGKYKDDPVDLR
CCCCCCCCCCCCHHH
60.17110879537
711SumoylationYKAEGKYKDDPVDLR
CCCCCCCCCCCCHHH
60.1728112733
711UbiquitinationYKAEGKYKDDPVDLR
CCCCCCCCCCCCHHH
60.1733845483
737PhosphorylationRDLKRGKSRESVDSR
HHHHCCCCCHHHHCC
44.0725849741
740PhosphorylationKRGKSRESVDSRDSS
HCCCCCHHHHCCCCH
30.0727362937
743PhosphorylationKSRESVDSRDSSHSR
CCCHHHHCCCCHHHH
35.5127362937
746PhosphorylationESVDSRDSSHSRERS
HHHHCCCCHHHHHHH
28.9226055452
747PhosphorylationSVDSRDSSHSRERSA
HHHCCCCHHHHHHHH
29.7620044836
749PhosphorylationDSRDSSHSRERSAEK
HCCCCHHHHHHHHHH
37.4720044836
753PhosphorylationSSHSRERSAEKTEKT
CHHHHHHHHHHHHHH
35.7126657352
756SumoylationSRERSAEKTEKTHKG
HHHHHHHHHHHHCCC
62.80-
756MethylationSRERSAEKTEKTHKG
HHHHHHHHHHHHCCC
62.8023748837
756SumoylationSRERSAEKTEKTHKG
HHHHHHHHHHHHCCC
62.8025218447
757PhosphorylationRERSAEKTEKTHKGS
HHHHHHHHHHHCCCC
33.9328176443
759SumoylationRSAEKTEKTHKGSKK
HHHHHHHHHCCCCHH
62.25-
759SumoylationRSAEKTEKTHKGSKK
HHHHHHHHHCCCCHH
62.2525218447
777PhosphorylationHRRARDRSRSSSSSS
HHHHHHHCCCCCCCC
40.5825137130
779PhosphorylationRARDRSRSSSSSSQS
HHHHHCCCCCCCCCC
35.5025849741
780PhosphorylationARDRSRSSSSSSQSS
HHHHCCCCCCCCCCC
32.8825137130
781PhosphorylationRDRSRSSSSSSQSSH
HHHCCCCCCCCCCCC
35.1725849741
782PhosphorylationDRSRSSSSSSQSSHS
HHCCCCCCCCCCCCC
35.6425137130
783PhosphorylationRSRSSSSSSQSSHSY
HCCCCCCCCCCCCCE
34.0525137130
784PhosphorylationSRSSSSSSQSSHSYK
CCCCCCCCCCCCCEE
35.7125137130
786PhosphorylationSSSSSSQSSHSYKAE
CCCCCCCCCCCEECH
31.7825849741
787PhosphorylationSSSSSQSSHSYKAEE
CCCCCCCCCCEECHH
14.6029449344
789PhosphorylationSSSQSSHSYKAEEYT
CCCCCCCCEECHHHC
30.2129449344
790PhosphorylationSSQSSHSYKAEEYTE
CCCCCCCEECHHHCH
14.5925137130
795PhosphorylationHSYKAEEYTEETEER
CCEECHHHCHHHHHH
15.7929255136
796PhosphorylationSYKAEEYTEETEERE
CEECHHHCHHHHHHH
30.5329255136
799PhosphorylationAEEYTEETEEREEST
CHHHCHHHHHHHHHC
36.5925849741
802MethylationYTEETEEREESTTGF
HCHHHHHHHHHCCCC
46.91115918909
805PhosphorylationETEEREESTTGFDKS
HHHHHHHHCCCCCHH
26.9029255136
806PhosphorylationTEEREESTTGFDKSR
HHHHHHHCCCCCHHH
33.9329255136
807PhosphorylationEEREESTTGFDKSRL
HHHHHHCCCCCHHHC
45.1729255136
8112-HydroxyisobutyrylationESTTGFDKSRLGTKD
HHCCCCCHHHCCCCC
34.90-
811AcetylationESTTGFDKSRLGTKD
HHCCCCCHHHCCCCC
34.9019608861
811UbiquitinationESTTGFDKSRLGTKD
HHCCCCCHHHCCCCC
34.9019608861
823PhosphorylationTKDFVGPSERGGGRA
CCCCCCCCCCCCCCC
33.7222817900
825MethylationDFVGPSERGGGRARG
CCCCCCCCCCCCCCC
54.0924395855
829MethylationPSERGGGRARGTFQF
CCCCCCCCCCCEEEE
25.1282954751
831MethylationERGGGRARGTFQFRA
CCCCCCCCCEEEEEE
43.2424395865
833PhosphorylationGGGRARGTFQFRARG
CCCCCCCEEEEEECC
14.5422817900
837DimethylationARGTFQFRARGRGWG
CCCEEEEEECCCCCC
16.76-
837MethylationARGTFQFRARGRGWG
CCCEEEEEECCCCCC
16.7630763353
839DimethylationGTFQFRARGRGWGRG
CEEEEEECCCCCCCC
30.96-
839MethylationGTFQFRARGRGWGRG
CEEEEEECCCCCCCC
30.9630763359
841DimethylationFQFRARGRGWGRGNY
EEEEECCCCCCCCCC
31.94-
841MethylationFQFRARGRGWGRGNY
EEEEECCCCCCCCCC
31.9424383761
845Asymmetric dimethylarginineARGRGWGRGNYSGNN
ECCCCCCCCCCCCCC
24.55-
845MethylationARGRGWGRGNYSGNN
ECCCCCCCCCCCCCC
24.5524383771
848PhosphorylationRGWGRGNYSGNNNNN
CCCCCCCCCCCCCCC
22.3025367160
849PhosphorylationGWGRGNYSGNNNNNS
CCCCCCCCCCCCCCC
38.7625367160
873PhosphorylationEEEWDPEYTPKSKKY
HHCCCCCCCCCCCCE
33.4630266825
874PhosphorylationEEWDPEYTPKSKKYY
HCCCCCCCCCCCCEE
23.6819664994
875UbiquitinationEWDPEYTPKSKKYYL
CCCCCCCCCCCCEEE
37.7132015554
876AcetylationWDPEYTPKSKKYYLH
CCCCCCCCCCCEEEC
68.0826051181
876SumoylationWDPEYTPKSKKYYLH
CCCCCCCCCCCEEEC
68.0828112733
876UbiquitinationWDPEYTPKSKKYYLH
CCCCCCCCCCCEEEC
68.0832015554
877PhosphorylationDPEYTPKSKKYYLHD
CCCCCCCCCCEEECC
35.2724732914
8792-HydroxyisobutyrylationEYTPKSKKYYLHDDR
CCCCCCCCEEECCCC
46.34-
879AcetylationEYTPKSKKYYLHDDR
CCCCCCCCEEECCCC
46.3427452117
879SumoylationEYTPKSKKYYLHDDR
CCCCCCCCEEECCCC
46.3428112733
880PhosphorylationYTPKSKKYYLHDDRE
CCCCCCCEEECCCCC
18.2620068231
881PhosphorylationTPKSKKYYLHDDREG
CCCCCCEEECCCCCC
13.3620068231
886MethylationKYYLHDDREGEGSDK
CEEECCCCCCCCCCC
60.93115918921
891PhosphorylationDDREGEGSDKWVSRG
CCCCCCCCCCCCCCC
31.5420068231
897MethylationGSDKWVSRGRGRGAF
CCCCCCCCCCCCCCC
29.2524395875
899MethylationDKWVSRGRGRGAFPR
CCCCCCCCCCCCCCC
30.4424395885
906MethylationRGRGAFPRGRGRFMF
CCCCCCCCCCCCEEE
40.7724396719
908DimethylationRGAFPRGRGRFMFRK
CCCCCCCCCCEEEEC
34.10-
908MethylationRGAFPRGRGRFMFRK
CCCCCCCCCCEEEEC
34.1054549131
910DimethylationAFPRGRGRFMFRKSS
CCCCCCCCEEEECCC
20.63-
910MethylationAFPRGRGRFMFRKSS
CCCCCCCCEEEECCC
20.6354549135
916O-linked_GlycosylationGRFMFRKSSTSPKWA
CCEEEECCCCCCCCC
34.2930379171
916PhosphorylationGRFMFRKSSTSPKWA
CCEEEECCCCCCCCC
34.2923403867
917PhosphorylationRFMFRKSSTSPKWAH
CEEEECCCCCCCCCC
35.6223403867
918PhosphorylationFMFRKSSTSPKWAHD
EEEECCCCCCCCCCC
57.0223403867
919PhosphorylationMFRKSSTSPKWAHDK
EEECCCCCCCCCCCC
26.8223403867
926AcetylationSPKWAHDKFSGEEGE
CCCCCCCCCCCCCCC
31.4023236377
927PhosphorylationPKWAHDKFSGEEGEI
CCCCCCCCCCCCCCC
16.4632142685
928PhosphorylationKWAHDKFSGEEGEIE
CCCCCCCCCCCCCCC
51.5429255136
938PhosphorylationEGEIEDDESGTENRE
CCCCCCCCCCCCCHH
64.4932142685
939PhosphorylationGEIEDDESGTENREE
CCCCCCCCCCCCHHH
58.9919664994
941PhosphorylationIEDDESGTENREEKD
CCCCCCCCCCHHHHC
39.0929255136
953PhosphorylationEKDNIQPTTE-----
HHCCCCCCCC-----
27.4723401153
954PhosphorylationKDNIQPTTE------
HCCCCCCCC------
46.5130278072

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
68YPhosphorylationKinaseSRCP12931
PSP
107YPhosphorylationKinaseSRCP12931
PSP
118YPhosphorylationKinaseSRCP12931
PSP
344YPhosphorylationKinaseSRCP12931
PSP
874TPhosphorylationKinaseCDK2P24941
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TR150_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TR150_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
POL_HV1H2gag-polphysical
20016921
PUF60_HUMANPUF60physical
26344197
RNPS1_HUMANRNPS1physical
26344197
RS19_HUMANRPS19physical
26344197
SSRP1_HUMANSSRP1physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TR150_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-221; LYS-401; LYS-455;LYS-519; LYS-709 AND LYS-811, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-253; SER-315;SER-320; SER-377; SER-379; SER-575; SER-682; THR-874; SER-928 ANDSER-939, AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-211; SER-243;SER-310; SER-315; SER-320; SER-323; TYR-328; SER-379; SER-408;SER-682; SER-928; SER-939 AND THR-941, AND MASS SPECTROMETRY.
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-928 AND SER-939, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232; SER-237; SER-240;SER-243; SER-248; SER-253; SER-379; SER-406; SER-408; SER-575;SER-682; THR-874; SER-928 AND SER-939, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND MASSSPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-248; SER-253AND SER-682, AND MASS SPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-248; SER-253AND SER-682, AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240; SER-243; SER-253;SER-320; SER-562; SER-575; SER-682; SER-684 AND THR-685, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211; SER-406 ANDSER-408, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-315; SER-320;SER-444; SER-508; SER-672; SER-682; SER-698; SER-939 AND THR-941, ANDMASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-248; SER-253;SER-682 AND SER-698, AND MASS SPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-682 AND THR-874, ANDMASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243 AND SER-682, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240; SER-243; SER-248;SER-253; SER-264; SER-268; SER-315; SER-320; SER-379; SER-406;SER-408; SER-535; SER-575; THR-662; SER-672; SER-682; SER-698;SER-823; THR-833; SER-928 AND SER-939, AND MASS SPECTROMETRY.
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
Kim J.-E., Tannenbaum S.R., White F.M.;
J. Proteome Res. 4:1339-1346(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211; SER-237; SER-243;SER-320; SER-379; SER-534; SER-535; SER-682 AND SER-939, AND MASSSPECTROMETRY.

TOP